![Alumis Inc](/common/images/company/N_ALMS.png)
Alumis Inc (ALMS)
NASDAQ
SOUTH SAN FRANCISCO, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (“Alumis” or the “Company”) (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.43 | 3.56255178128 | 12.07 | 13 | 10.45 | 154311 | 11.75520326 | CS |
4 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
12 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
26 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
52 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
156 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
260 | -1 | -7.40740740741 | 13.5 | 13.5 | 10.45 | 245780 | 12.39147551 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.